Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of “Hold” from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been given a consensus recommendation of “Hold” by the fifteen research firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $18.6154.

ACHC has been the topic of a number of research analyst reports. Jefferies Financial Group lowered Acadia Healthcare to a “hold” rating in a research note on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, December 3rd. Royal Bank Of Canada dropped their target price on shares of Acadia Healthcare from $19.00 to $17.00 and set an “outperform” rating for the company in a research report on Wednesday, January 14th. Guggenheim decreased their price target on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a report on Monday, November 10th. Finally, TD Cowen reaffirmed a “reduce” rating on shares of Acadia Healthcare in a report on Friday, January 16th.

Acadia Healthcare Price Performance

ACHC stock opened at $13.44 on Friday. The firm has a 50 day moving average of $14.35 and a 200-day moving average of $19.28. The firm has a market capitalization of $1.24 billion, a P/E ratio of 11.49, a price-to-earnings-growth ratio of 3.71 and a beta of 0.88. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $45.47. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.01. The business had revenue of $851.57 million for the quarter, compared to analysts’ expectations of $852.43 million. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, sell-side analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

A number of large investors have recently modified their holdings of ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Acadia Healthcare in the first quarter worth approximately $1,600,000. Goldman Sachs Group Inc. lifted its holdings in shares of Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after acquiring an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after purchasing an additional 27,207 shares during the last quarter. Public Employees Retirement System of Ohio raised its position in Acadia Healthcare by 2.6% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 30,468 shares of the company’s stock worth $691,000 after purchasing an additional 760 shares during the period. Finally, Signaturefd LLC lifted its stake in Acadia Healthcare by 1,451.7% in the second quarter. Signaturefd LLC now owns 5,043 shares of the company’s stock worth $114,000 after purchasing an additional 4,718 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.